Showing Results for: “diabetes exercise”

The American Diabetes Association (ADA) announces this year’s Professional Interest Group and Women’s Interprofessional Network Award recipients The American Diabetes Association® (ADA) is proud to announce the recipients of the 2020 Professional Interest Group and Women’s Interprofessional Network Awards. These awards, presented by various membership groups, recognize academics, health care providers and educators who have contributed to advances in specialized areas of diabetes care and research. Each recipient has shown outstanding commitment to achieving the vision of the ADA: life free of

Following the release of President Trump’s budget proposal for Fiscal Year 2021, Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement: “Yesterday, the White House announced its FY2021 budget. While we were encouraged to see that the President recommended extending the highly successful Special Diabetes Program (SDP), we ask Congress to go further and provide a long-term renewal for SDP. In addition, far too many other public health and biomedical research programs would be subject to severe cuts under the President’s proposal

Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lowering medications should have glucagon, preferable a ready-to-use formulation The American Diabetes Association ® (ADA) and Xeris Pharmaceuticals ® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are pleased to announce a multi-year strategic partnership to reinforce the importance of prescribing glucagon, preferably ready-to-use, for all individuals with diabetes who are treated with insulin and/or insulin secretagogues or those at high risk of hypoglycemia (low blood glucose

Regular physical activity is an important part of managing diabetes or dealing with prediabetes. Find what you need to know, from getting started to maintaining momentum.

A story by Marlee Seibold.

Data Addresses Gaps in Preventive Prescriptions Therapy, Emphasizing the Importance of Multifaceted Interventions Today, findings from the COORDINATE-Diabetes trial demonstrated that multi-disciplinary care between cardiologists, diabetes specialists and other team members can significantly increase the prescriptions of evidence-based therapies to help treat patients with both type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), commonly known as heart disease. The trial was presented as a late-breaking symposium today at the 83rd Scientific Sessions of the American

Reality show style competition showcases novel diabetes business ideas with potential funders as part of ADA 83 rd Scientific Sessions Today, the American Diabetes Association® (ADA) announced the winners of its inaugural pitch competition at the 83rd Scientific Sessions of the American Diabetes Association (ADA) in San Diego, CA. The first-ever Innovation Challenge highlighted six business concepts for diabetes care before a panel of potential funders, with the goal of connecting innovators and startup companies with transformative solutions and ideas. The winners, Minutia, Oregon Health &

American Diabetes Association Symposium Demonstrates Benefits of Once Weekly Drug for Weight Loss and Glycemic Control Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more weight loss in individuals with diabetes than any other medication to date. The results were presented at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA and were simultaneously published in The Lancet . Obesity impacts 650 million people worldwide including nearly half of all Americans and

First-of-Its-Kind Study Compares Open-Source Automated Insulin Delivery to Sensor-Augmented Pump Therapy Results from the CREATE Trial demonstrated open-source automated insulin delivery (AID) systems are a safe and effective therapy for people with type 1 diabetes. Findings from the randomized controlled trial (RCT) comparing open-source AID to sensor-augmented pump therapy (SAPT) were presented today at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Open-source AID systems were developed to reduce the burden of living with diabetes by combining an insulin pump